Suzhou Medsys Tech Co Ltd Total Assets
Suzhou Medsys Tech Co Ltd total assets. Based on the latest financial reports, Suzhou Medsys Tech Co Ltd (603990) holds total assets worth CN¥1.22 Billion CNY (≈ $177.85 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Suzhou Medsys Tech Co Ltd for the company's overall valuation and market capitalisation.
Total Assets of Suzhou Medsys Tech Co Ltd (2011–2025)
Total assets of Suzhou Medsys Tech Co Ltd from 2011 to 2025. This chart illustrates how Suzhou Medsys Tech Co Ltd's total assets have evolved over time, based on quarterly financial data. See Suzhou Medsys Tech Co Ltd (603990) share price today for real-time trading data and today's change.
Suzhou Medsys Tech Co Ltd - Asset Composition Analysis
Suzhou Medsys Tech Co Ltd Total Assets Breakdown (December 2025)
Suzhou Medsys Tech Co Ltd total assets breakdown as of December 2025. Suzhou Medsys Tech Co Ltd's total assets of CN¥1.22 Billion consist of 63.8% current assets and 36.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 23.5% |
| Accounts Receivable | CN¥461.90 Million | 37.0% |
| Inventory | CN¥31.43 Million | 2.5% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥126.89 Million | 10.2% |
| Goodwill | CN¥31.17 Million | 2.5% |
Asset Composition Trend (2011–2025)
This chart illustrates how Suzhou Medsys Tech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Suzhou Medsys Tech Co Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Suzhou Medsys Tech Co Ltd's current assets represent 63.8% of total assets in 2025, a decrease from 92.4% in 2011.
- Cash Position: Cash and equivalents constituted 23.5% of total assets in 2025, up from 18.6% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 12.0% of total assets, an increase from 4.0% in 2011.
- Asset Diversification: The largest asset category is accounts receivable at 37.0% of total assets.
Suzhou Medsys Tech Co Ltd Competitors by Total Assets
Key competitors of Suzhou Medsys Tech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.30 Billion |
|
Painchek Ltd
AU:PCK
|
Australia | AU$7.63 Million |
|
Medadvisor Ltd
AU:MDR
|
Australia | AU$39.84 Million |
|
Trivarx Ltd
AU:TRI
|
Australia | AU$16.53 Million |
|
Intelicare Holdings Ltd
AU:ICR
|
Australia | AU$3.34 Million |
|
Newtopia Inc
V:NEWU
|
Canada | CA$664.83K |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
Suzhou Medsys Tech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.35 | 2.95 | 4.18 |
| Quick Ratio | 2.25 | 2.82 | 4.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥443.29 Million | CN¥557.30 Million | CN¥771.56 Million |
Suzhou Medsys Tech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Suzhou Medsys Tech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.81 |
| Latest Market Cap to Assets Ratio | 0.74 |
| Asset Growth Rate (YoY) | -60.5% |
| Total Assets | CN¥1.25 Billion |
| Market Capitalization | $921.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Suzhou Medsys Tech Co Ltd's assets below their book value (0.74x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Suzhou Medsys Tech Co Ltd's assets decreased by 60.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Suzhou Medsys Tech Co Ltd (2011–2025)
The table below shows the annual total assets of Suzhou Medsys Tech Co Ltd from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.25 Billion ≈ $182.75 Million |
-60.53% |
| 2024-12-31 | CN¥3.16 Billion ≈ $463.00 Million |
-19.19% |
| 2023-12-31 | CN¥3.92 Billion ≈ $572.93 Million |
+140.14% |
| 2022-12-31 | CN¥1.63 Billion ≈ $238.58 Million |
+24.24% |
| 2021-12-31 | CN¥1.31 Billion ≈ $192.04 Million |
-13.76% |
| 2020-12-31 | CN¥1.52 Billion ≈ $222.67 Million |
+100.15% |
| 2019-12-31 | CN¥760.27 Million ≈ $111.25 Million |
+6.00% |
| 2018-12-31 | CN¥717.21 Million ≈ $104.95 Million |
+14.48% |
| 2017-12-31 | CN¥626.50 Million ≈ $91.68 Million |
-9.25% |
| 2016-12-31 | CN¥690.34 Million ≈ $101.02 Million |
+58.58% |
| 2015-12-31 | CN¥435.34 Million ≈ $63.70 Million |
+56.13% |
| 2014-12-31 | CN¥278.84 Million ≈ $40.80 Million |
+42.81% |
| 2013-12-31 | CN¥195.25 Million ≈ $28.57 Million |
+38.23% |
| 2012-12-31 | CN¥141.25 Million ≈ $20.67 Million |
+64.78% |
| 2011-12-31 | CN¥85.72 Million ≈ $12.54 Million |
-- |
About Suzhou Medsys Tech Co Ltd
Suzhou MedicalSystem Technology Co., Ltd. provides solutions in clinical informatics and digital hospital field in China. It offers DoCare anesthesia clinical information system that focuses on serving the perioperative clinical work; and provides streamlined, informational, automatic, and intelligent integrated management platform for clinical business. The company also provides DoCare intensive… Read more